• It's your time to find the health care job that fits you!
  • It's your choice to choose a health care recruiting firm with your interests in mind!
  • It's your turn to find a career in health care that is right for you!
  • It's your move, make it a good one!
  • It's YOUR health care career!
Ear, Nose, and Throat News

Noise Exposure Can Cause Long-Lasting Changes To Sensory Pathways; Touch-Sensing Nerve Cells May Lead To Future Tinnitus Treatments

Fri, 03 Feb 2012 00:00:00 PST
We all know that it can take a little while for our hearing to bounce back after listening to our iPods too loud or attending a raucous concert. But new research at the University of Michigan Health System suggests over-exposure to noise can actually cause more lasting changes to our auditory circuitry - changes that may lead to tinnitus, commonly known as ringing in the ears...

Head And Neck Cancer Cells Destroyed By Grape Seed Extract, But Healthy Cells Are Unharmed
Mon, 30 Jan 2012 00:00:00 PST
Nearly 12,000 people will die of head and neck cancer in the United States this year and worldwide cases will exceed half a million. A study published in the journal Carcinogenesisshows that in both cell lines and mouse models, grape seed extract (GSE) kills head and neck squamous cell carcinoma cells, while leaving healthy cells unharmed...

Increased Risk For Transplant Patients Who Develop Head & Neck Cancer
Mon, 30 Jan 2012 00:00:00 PST
Transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely than their non-transplant counterparts to survive past one year of diagnosis, according to a new study from Henry Ford Hospital in Detroit...

Head And Neck Cancer Recurrences Detected Earlier By Routine Follow-Up Scans
Sun, 29 Jan 2012 00:00:00 PST
Routine use of positron emission tomography/computed tomography (PET/CT) scans in head and neck cancer patient follow-up can detect local recurrences before they become clinically apparent and may improve the outcome of subsequent salvage therapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM...

Erlotinib Dose-Adjusted For Smoking Status Effective As First Treatment For Head And Neck Cancer
Fri, 27 Jan 2012 04:00:00 PST
Head and neck cancers respond well to the anti-cancer drug erlotinib when it is administered before surgery and a stronger dose is given to patients who smoke, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM...


 



SEARCHING FOR A JOB!
Contact us by filling out the simple form below to get started.